Unknown

Dataset Information

Conjugating Prussian blue nanoparticles onto antigen-specific T cells as a combined nanoimmunotherapy.


ABSTRACT:

Aim

To engineer a novel nanoimmunotherapy comprising Prussian blue nanoparticles (PBNPs) conjugated to antigen-specific cytotoxic T lymphocytes (CTL), which leverages PBNPs for their photothermal therapy (PTT) capabilities and Epstein-Barr virus (EBV) antigen-specific CTL for their ability to traffic to and destroy EBV antigen-expressing target cells.

Materials & methods

PBNPs and CTL were independently biofunctionalized. Subsequently, PBNPs were conjugated onto CTL using avidin-biotin interactions. The resultant cell-nanoparticle construct (CTL:PBNPs) were analyzed for their physical, phenotypic and functional properties.

Results

Both PBNPs and CTL maintained their intrinsic physical, phenotypic and functional properties within the CTL:PBNPs.

Conclusion

This s

SUBMITTER: Burga RA 

PROVIDER: S-EPMC4941545 | biostudies-literature | 2016 Jul

REPOSITORIES: biostudies-literature